Press releases

Month Year

May 25, 2005

TAXUS V Sub-Population Data Further Support Efficacy of TAXUS® EXPRESS²™ Stent System in Diabetic Patients

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the efficacy of...
May 25, 2005

Trial Results Support Safety for Next-Generation TAXUS® Liberté™ Paclitaxel-Eluting Stent System

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced thirty-day safety data from its ATLAS clinical trial. ATLAS is the first trial using Boston...
May 25, 2005

ARRIVE Registry Supports Positive Safety Profile of TAXUS® Express²™ Stent System in Diabetics and Other Patients

and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results from its ARRIVE and Milestone II registries. The results were announced during a symposia...
May 24, 2005

Moderate-Release TAXUS® EXPRESS²™ Coronary Stent System Demonstrates Excellent Durability in High-Risk Patients Out to Two Years

and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS VI clinical trial. The data demonstrated that the safety and...
May 24, 2005

TAXUS V IVUS Results Support Safety and Efficacy in Most Challenging Lesions and Highest-Risk Patients

and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced intravascular ultrasound (IVUS) follow-up data from its TAXUS V clinical trial, supporting the safety...

Show per page

Top